BID and bipolar disorder: The increased levels of the anti-apoptotic/pro–cell survival markers MCL1 and BCL2 and unchanged levels of the pro–cell death markers BID and BAX suggest a balance toward activated cell survival mechanisms in the midbrains of individuals with schizophrenia and bipolar disorder.